POAG | PEXG | PSPHG | p Value | |
---|---|---|---|---|
Age (years) (SD) | 68.9 (12.1) | 75.7 (7.8) | 76.4 (10.5) | < 0.03 |
Preoperative IOP (mm Hg) (SD) | 26.3 (7.7) | 30.5 (8.1) | 28.9 (10.0) | 0.058 |
Postoperative IOP (mm Hg) (SD) | ||||
12 months | 14.3 (3.2) | 13.2 (3.5) | 12.5 (3.4) | NS |
24 months | 12.9 (3.3) | 13.3 (3.5) | 13.4 (4.9) | NS |
Complete success rate (%) 30 months | 75.8 | 71 | 57 | NS |
Qualified success rate (%) 30 months | 98 | 100 | 100 | NS |
Number of preoperative glaucoma medications (SE) | 2.1 (0.6) | 2.4 (0.8) | 2.4 (0.7) | NS |
Number of postoperative glaucoma medications (SE) | 0.2 (0.3) | 0.2 (0.4) | 0.3 (0.4) | NS |
Number of patients having 5-FU injections | 11/52 (21 %) | 4/20 (20%) | 3/14 (21%) | NS |
Number of patients having goniopuncture | 18/52 (21%) | 10/20 (50%) | 6/ 64 (43%) | NS |
↵POAG patients are significantly younger than those with PEXG or PSPHG.
NS = not significant; IOP = intraocular pressure; SE = standard error; SD = standard deviation; 5-FU = 5-fluorouracil.